MRI Findings May Help Predict Development of Breast Cancer

Share this content:
MRI Findings May Help Predict Development of Breast Cancer
MRI Findings May Help Predict Development of Breast Cancer

TUESDAY, May 12, 2015 (HealthDay News) -- Among high-risk women undergoing magnetic resonance imaging (MRI) screening, those with background parenchymal enhancement are nine times more likely to develop breast cancer over the next couple of years, according to a new study. The findings, published online May 12 in Radiology, suggest that MRIs could have value beyond detecting breast cancer.

"It's possible that down the line, we could use it to help predict which women will develop breast cancer," study coauthor Habib Rahbar, M.D., a radiologist at the University of Washington School of Medicine in Seattle, told HealthDay.

The new findings are based on medical records from 487 women who underwent MRI screening for breast cancer between 2006 and 2011. All fit the American Cancer Society's definition of high risk. During the study period, 23 women were diagnosed with breast cancer -- an average of two years after their first MRI screening.

Rahbar's team then compared those patients with high-risk women who had not developed breast cancer. They found that the presence of background parenchymal enhancement on a woman's initial MRI seemed to predict a greater cancer risk. Women with at least mild background parenchymal enhancement were nine times more likely to develop the disease, versus those without the MRI finding.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »